Curvularia inaequalis
Star0
Explore a selection of our essential drug information below, or:
Identification
- Summary
Curvularia inaequalis is an extract from Curvularia inaequalis used in allergy testing.
- Generic Name
- Curvularia inaequalis
- DrugBank Accession Number
- DB10697
- Background
Curvularia inaequalis is a fungus which can provoke allergic reactions. Curvularia inaequalis extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Curvularia inequalis allergenic extract
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Curvularia Injection, solution 20000 [PNU]/1mL Percutaneous; Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-22 US Curvularia inaequalis Injection, solution 40000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Curvularia inequalis Injection, solution 10000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Curvularia inequalis Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Curvularia inequalis Injection, solution 20000 [PNU]/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Mold Mix 2 Curvularia inaequalis (40000 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (40000 [PNU]/1mL) + Fusarium graminearum (40000 [PNU]/1mL) + Mucor plumbeus (40000 [PNU]/1mL) + Rhizopus arrhizus var. arrhizus (40000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-24 US Mold Mix 2 Curvularia inaequalis (20000 [PNU]/1mL) + Aureobasidium pullulans var. pullutans (20000 [PNU]/1mL) + Fusarium graminearum (20000 [PNU]/1mL) + Mucor plumbeus (20000 [PNU]/1mL) + Rhizopus arrhizus var. arrhizus (20000 [PNU]/1mL) Injection, solution Subcutaneous ALK-Abello, Inc. 1965-01-01 2023-05-24 US Mold Mix 2 Curvularia inaequalis (0.1 g/1mL) + Aureobasidium pullulans var. pullutans (0.1 g/1mL) + Fusarium graminearum (0.1 g/1mL) + Mucor plumbeus (0.1 g/1mL) + Rhizopus arrhizus var. arrhizus (0.1 g/1mL) Injection, solution Percutaneous ALK-Abello, Inc. 1998-02-23 2023-05-24 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- W042YAB8JC
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- PubChem Substance
- 347910829
- 999438
- Wikipedia
- Curvularia_inaequalis
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Percutaneous; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Percutaneous Injection, solution Subcutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53